Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Viral protein 1 (VP1) is one of four major structural proteins that compose the capsid shell of picornaviruses, a large family of non-enveloped, positive-sense single-stranded RNA viruses. The mature virion contains 60 copies each of four proteins—VP4, VP2, VP3, and VP1, with VP1 forming prominent features on the external surface at five-fold axes known as "canyons", which often serve as sites for cellular receptor binding. The "jelly-roll" β-barrel fold is characteristic for this class. During infection, conformational changes in the capsid—often involving release or rearrangement around VP4/VP1 regions—enable delivery of viral RNA into host cells through membrane penetration mechanisms. The external loops on VP1 are key antigenic determinants targeted by neutralizing antibodies but also display high sequence variability among strains. Some antivirals act by occupying a hydrophobic cavity within VP1 ("pocket factor"), thereby blocking necessary structural transitions during cell entry. Picornaviruses cause diverse human diseases ranging from mild respiratory illness (rhinoviruses) to severe neurological disease (poliovirus), with their pathogenicity closely linked to efficient assembly/disassembly cycles mediated by their structural proteins including VP1.
Drugs targeting this molecule typically: - Bind to a hydrophobic pocket within VP1 ("pocket factor"), stabilizing the capsid and preventing conformational changes required for uncoating and genome release into host cells
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral protein 1 of picornavirus capsid (VP1).